Patent · US Active

Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

US8518949B2 · kind B2 · utility

20Cited by
19References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 4, 2012
Grant dateAug 27, 2013
Priority date
Expiry dateJun 4, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Crystalline polymorphous forms of the rifaximin (INN) antibiotic named rifaximin δ and rifaximin ε useful in the production of medicinal preparations containing rifaximin for oral and topical use and obtained by means of a crystallization process carried out by hot-dissolving the raw rifaximin in ethyl alcohol and by causing the crystallization of the product by addition of water at a determinate temperature and for a determinate period of time, followed by a drying carried out under controlled conditions until reaching a settled water content in the end product, are the object of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.